The screening mammography paradox: better when found, perhaps better not to find
Author:
Open Access
- 27 May 2008
- journal article
- Published by Springer Nature in British Journal of Cancer
- Vol. 98 (11) , 1729-1730
Abstract
No abstract availableKeywords
This publication has 12 references indexed in Scilit:
- Screen-detected vs symptomatic breast cancer: is improved survival due to stage migration alone?British Journal of Cancer, 2008
- Chapter 6: Modeling the Impact of Treatment and Screening on U.S. Breast Cancer Mortality: A Bayesian ApproachJNCI Monographs, 2006
- Chapter 7: The Wisconsin Breast Cancer Epidemiology Simulation ModelJNCI Monographs, 2006
- TAILORx: Trial Assigning Individualized Options for Treatment (Rx)Clinical Breast Cancer, 2006
- Gene Expression and Benefit of Chemotherapy in Women With Node-Negative, Estrogen Receptor–Positive Breast CancerJournal of Clinical Oncology, 2006
- Estrogen-Receptor Status and Outcomes of Modern Chemotherapy for Patients With Node-Positive Breast CancerJAMA, 2006
- Effect of Screening and Adjuvant Therapy on Mortality from Breast CancerNew England Journal of Medicine, 2005
- Role of Detection Method in Predicting Breast Cancer Survival: Analysis of Randomized Screening TrialsJNCI: Journal of the National Cancer Institute, 2005
- A Multigene Assay to Predict Recurrence of Tamoxifen-Treated, Node-Negative Breast CancerNew England Journal of Medicine, 2004
- Risk for Distant Recurrence of Breast Cancer Detected by Mammography Screening or Other MethodsJAMA, 2004